Clinical Trials Sponsored by iOx Therapeutics

Total 6829 results

iOmx Therapeutics AG

Recruiting

A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically

Solid Tumor

Spain, Belgium
Io Therapeutics

Completed

Study of IRX4204 for Treatment of Early Parkinson's Disease

Parkinson's Disease

United States
Io Therapeutics

Completed

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Castration Resistant Prostate Cancer

United States
iOx Therapeutics
Merck Sharp & Dohme LLC

Terminated

IMM60 and Pembrolizumab in Melanoma and NSCLC

Melanoma | Non-small Cell Lung Cancer

Spain, United States, United Kingdom
Fox Chase Cancer Center
WindMIL Therapeutics

Withdrawn

Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab

NSCLC | SCLC
Io Therapeutics
Dartmouth College

Suspended

Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC

Lung Cancer, Nonsmall Cell

United States
Allyx Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Recruiting

A Study to Assess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson's

Parkinson Disease

United States
Acorda Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Idiopathic Parkinson's Disease

Israel, Serbia, United Kingdom
Allyx Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Active, not recruiting

Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers

Dementia | Alzheimer Disease

United States
Motus Therapeutics, Inc.
Michael J. Fox Foundation for Parkinson's Research

Terminated

A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation (MOVE-PD)

Parkinson's Disease

United States
Ranok Therapeutics (Hangzhou) Co., Ltd.

Recruiting

A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

Advanced Solid Tumor | DLBCL

United States
Medy-Tox

Completed

Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume

Aging

Korea, Republic of
Medy-Tox

Completed

Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of MT921 in Healthy Subjects

Healthy Volunteers

Korea, Republic of
Medy-Tox

Completed

Pivotal Clinical Study to Assess the Anti-adhesive Effect and Safety of ABT13107 Applied to Postoperative Intrauterine

Postoperative Adhesion of Uterus

Korea, Republic of
Medy-Tox

Completed

Observational Study to Determine the Efficacy and Safety of Potenfill for Temporary Penile Enhancement

Penile Enhancement

Korea, Republic of
Medy-Tox

Completed

The Efficacy and Safety of Repeat-dose Potenfill for Temporary Penile Enhancement

Penile Enhancement | Penile Girth Enhancement

Korea, Republic of
Medy-Tox

Completed

Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

Overweight

Korea, Republic of
Medy-Tox

Unknown

Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder

Overactive Bladder

Korea, Republic of
Medy-Tox

Unknown

Long-term Open-label Treatment of Moderate to Severe Glabellar Lines With CORETOX®

Glabellar Frown Lines

Korea, Republic of
Medy-Tox

Completed

Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line

Glabellar Frown Lines
Medy-Tox

Completed

MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity

Spasticity, Muscle
Medy-Tox

Completed

Efficacy and Safety of MEDITOXIN® in Cervical Dystonia (CD Phase III)

Cervical Dystonia
Medy-Tox

Completed

Efficacy and Safety Study of MT10109L in the Treatment of Glabella Line(Including a Preliminary Study to Evaluate Safety of MT10109L)

Glabella Line Severity

Korea, Republic of
Medy-Tox

Completed

Medytoxin® Treatment in Patients With Benign Masseteric Hypertrophy

Hypertrophy of Masseter Muscle

Korea, Republic of
Medy-Tox

Completed

Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers

Hyperhidrosis | Anhidrotic Area

Korea, Republic of
Medy-Tox

Completed

Efficacy and Safety of Potenfill for Temporary Penile Enhancement

Penile Enhancement

Korea, Republic of
Medy-Tox

Completed

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

Glabellar Lines
Medy-Tox

Completed

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm

Essential Blepharospasm
Medy-Tox

Completed

Efficacy and Safety Evaluation Study of Neuramis® Deep Lidocaine in Correction of Nasolabial Fold

Nasolabial Fold

Korea, Republic of
Medy-Tox

Completed

Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia

Cervical Dystonia

Australia
Medy-Tox

Completed

Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat

Submental Fat

Korea, Republic of
Medy-Tox

Completed

Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines

Lateral Canthal Lines

Australia
Medy-Tox

Completed

Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines

Glabellar Frown Lines

Australia
Medy-Tox

Completed

A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat

Submental Fat

Korea, Republic of
Medy-Tox

Completed

Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity

Muscle Spasticity
Medy-Tox

Completed

Efficacy and Safety Study of Neuramis in Correction of Nasolabial Fold

Nasolabial Fold

Korea, Republic of
Medy-Tox

Completed

Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers

Healthy

Korea, Republic of
Medy-Tox

Completed

The Efficacy and Safety of MEDITOXIN® in Children With Cerebral Palsy

Muscle Spasticity

Korea, Republic of
Medy-Tox

Completed

MEDITOXIN® in Treatment of Crow's Feet Line

Crow's Feet Lines

Korea, Republic of
Akebia Therapeutics
Cyclerion Therapeutics

Completed

A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

Type 2 Diabetes Mellitus With Diabetic Nephropathy

United States
Akebia Therapeutics
Cyclerion Therapeutics

Completed

A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) (CAPACITY-HFpEF)

Heart Failure With Preserved Ejection Fraction

United States, Canada
Medy-Tox

Completed

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Lateral Canthal Lines | Glabellar Lines

United States, Russian Federation, Germany, Canada, Belgium, United Kingdom
Medy-Tox

Completed

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Glabellar Frown Lines

Australia
Medy-Tox

Completed

MT10109L in the Treatment of Lateral Canthal Lines

Lateral Canthal Lines

United States, Russian Federation, United Kingdom
Medy-Tox

Completed

MT10109L in the Treatment of Glabellar Lines

Glabellar Lines

United States, Belgium, Russian Federation
Medy-Tox

Completed

MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines

Lateral Canthal Lines | Glabellar Lines

United States, Germany, Canada
Medy-Tox

Completed

MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)

Lateral Canthal Lines | Glabellar Lines

United States, Germany, Canada, United Kingdom
Medy-Tox

Completed

CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1)

Muscle Spasticity

Korea, Republic of
Medy-Tox

Completed

CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3)

Muscle Spasticity

Korea, Republic of
Medy-Tox

Completed

Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face

Mid Face Volume Loss

China

3

Subscribe